Background/Aims: Diabetes type 2, metabolic syndrome or non-alcoholic fatty liver disease are insulin resistance-related metabolic disorders, which lack a better prognosis before their full establishment. We studied the importance of the intracellular scaffold protein integrin linked kinaes (ILK) as a key modulator in the initial pathogenesis and the early progression of those insulin resistance-related disorders. Methods: Adult mice with a global transgenic downregulation of ILK expression (cKD-ILK) and littermates without that depletion (CT) were fed with either standard (STD) or high fat (HFD) diets during 2 and 6 weeks. Weights, blood glucose and other systemic biochemical parameters were determined in animals under fasting conditions and after glucose or pyruvate intraperitoneal injections to test their tolerance. In RNA or proteins extracted from insulin-sensitive tissues, we determined by reverse transcriptionquantitative PCR and western blot the expression of ILK, metabolites transporters and other metabolism and inflammatory markers. Glucose uptake capacity was studied in freshly isolated tissues. Results: HFD feeding was able to early and progressively increase glycaemia, insulinemia, circulating glycerol, body weight gain, liver-mediated gluconeogenesis along this time lapse, but cKD-ILK have all these systemic misbalances exacerbated compared to CT in the same HFD time lapse. Interestingly, the tisular expression of ILK in HFD-fed CT was dramatically downregulated in white adipose tissue (WAT), skeletal muscle and liver at the Hatem-Vaquero et al.: ILK Participates in Insulin Resistance Pathogenesis same extent of the original ILK downregulation of cKD-ILK. We previously published that basal STD-fed cKD-ILK compared to basal STD-CT have different expression of glucose transporters GLUT4 in WAT and skeletal muscle. In the same STD-fed cKD-ILK, we observed here the increased expressions of hepatic GLUT2 and WAT pro-inflammatory cytokines TNF-α and MCP-1. The administration of HFD exacerbated the expression changes in cKD-ILK of these and other markers related to the imbalanced metabolism observed, such as WAT lipolysis (HSL), hepatic gluconeogenesis (PCK-1) and glycerol transport (AQP9). Conclusion: ILK expression may be taken as a predictive determinant of metabolic disorders establishment, because its downregulation seems to correlate with the early imbalance of glucose and glycerol transport and the subsequent loss of systemic homeostasis of these metabolites.
Introduction
Chronic metabolic disorders connected to insulin resistance, such as diabetes type 2, nonalcoholic fatty liver disease or the group defined as metabolic syndrome have a multifactorial etiology and implicates the inter-communication between metabolically relevant tissues, which complicates the quest of the pathogenesis. Some of the characteristic events that may occur during their progression are: 1) hyperglycemia together with the defective transport and disposal of glucose in the tissues [1] , 2) the increase of lipolysis events within the white adipose tissue (WAT) [2] and 3) the increase of gluconeogenesis in the liver [3, 4] .
Erratic expression of transmembrane transporters such as glucose transporters GLUT4 in muscle and WAT, GLUT2 in the liver or hepatic glycerol channel aquaporin AQP9 [5] [6] [7] are implicated during the dysfunctional cellular uptake from blood stream of glucose and lipolysis sub-products. Pancreatic β-cell expansion also correlates with global and complex metabolites changes on rodent models in response to high fat diet (HFD) [8] . Moreover, WAT increases the secretion of several pro-inflammatory adipokines such as tumor necrosis factor α (TNFα) and monocyte chemoattractant protein-1 (MCP-1), which allow a general lowgrade inflammatory state in WAT and other organs [2] . In turn, the increased circulating proinflammatory adipokines and metabolic products will persevere the unbalanced processing of metabolites.
In the search for the origin of insulin sensitivity loss, others and we suggested that integrin-linked kinase (ILK) might be a potential modulator of insulin sensitivity decrease [9] [10] [11] . ILK is an intracellular scaffold protein which is able to mediate between the extracellular environment and the cell, and according to our previous research it may be assigned as a basal transcriptional and/or post-transduction modulator of transmembrane transporters such as GLUT4 or AQP2 [9, 12, 13] . Here we further elucidate the implication of ILK in the pathogenesis of insulin resistance during the early establishment of a HFD-fed mice model [15] [16] [17] . We challenged transgenic mice with global ILK downregulated expression in their adulthood (cKD-ILK) [9] and their control counterparts (CT, with the same transgenic background but without ILK depletion induced) with either HFD or the corresponding low fat standard diet (STD) for a short-term period of 2 and 6 weeks. During this HFD-based early stage, the expression of ILK in insulin sensitive tissues relates with the early unbalance in glucose and glycerol transport, pro-inflammation, lipolysis, gluconeogenesis and subsequent body weight gain and systemic glucose and insulin loss of homeostasis.
Materials and Methods

Animal model and diets
All procedures involving animals were approved by the Institutional Animal Care Committees of the University of Alcalá and Comunidad de Madrid, in agreement with the guidelines established by the European Community Council Directives (2010/63/EU). Adult conditional ILK-deficient mice (cKD-ILK) were generated as previously described [9] . Briefly, C57Bl/6 mice homozygous for floxed ILK flanked by
Analysis of biochemical parameters
In vivo blood parameters determinations were taken along the time via tail bleeding in a group of cKD-ILK and CT fed with HFD during 6 weeks at the following time points: 0, 2 and 6 weeks of HFD. Fasting glucose was determined using a glucometer (Accu-Check Aviva; Roche, Basel, Switzerland). Heparinized blood samples were centrifuged (900 g, 15 min, 4ºC) and commercial kits were used to determine in plasma insulin (Cloud-Clone Corp., Houston, TX, USA), free glycerol, free fatty acid, Plasma triglycerides, total cholesterol and HDL (Biovision, Milpitas, CA, USA). The homeostasis model assessment of insulin resistance (HOMA-IR) in the animals were calculated according to the formula fasting glucose (mg/dl) × fasting insulin (mU/L)/405.
Glucose and pyruvate tolerance tests (GTT and PTT)
cKD-ILK and CT fed with HFD during 6 weeks were devoted to perform tolerance tests along the same time points: 0, 2 and 6 weeks of HFD. The mice fasting for16 h were i.p. injected with glucose or sodium pyruvate (2 mg per g of body weight, Sigma-Aldrich, St. Louis, MO, USA) and blood glucose levels were measured at times 0, 30, 90, 150 and 180 min after bolus. Total areas under the curve (AUC) obtained during GTT and PTT were calculated [9, 18] .
Glucose uptake assay
Glucose uptake capacity of freshly excised tissues was performed as described previously [9] . Briefly, excised epididymal WAT and vastus explants from fasting mice (exposed to STD or HFD diets during 2 or 6 weeeks) were incubated ex-vivo under 95% O2 + 5% CO2 conditions at 37°C for 15 min, in free in DMEM free of serum, glucose and sodium pyruvate (Thermo Fisher Scientific Waltham, MA, USA). Insulin (100 nM, Actrapid, Novo Nordisk A/S, Bagsvaerd, Denmark) was added for additional 15 min and 0.1mM of the fluorescent D-glucose analogue 2-[N(7nitrobenz-2-oxa-1, 3-diazol-4-yl)amino]-2-deoxy-glucose (2-NBDG, Sigma-Aldrich, St. Louis, MO, USA) was added for 30 min more. Free 2-NBDG was washed out 3 times with cold PBS, tissues were lysed and intracellular 2-NBDG fluorescence (excitation 485 nm, emission 535 nm) was measured (VICTORX4, PerkinElmer, Waltham, MA, USA). Glucose uptake rates were calculated after subtracting the tissue background signal (negative control, without 2-NBDG) and normalized to tissue weights.
Reverse transcription-quantitative polymerase chain reaction (RT-qPCR)
All products and equipment used were from Thermo Fisher Scientific (Waltham, MA, USA). Tissues (epididymal WAT, vastus or liver) collected from fasting mice exposed to the diets (STD or HFD) during 2 or 6 weeeks were processed with Trizol to extract total RNA. Equal amounts of RNA were transcribed to cDNA with High Capacity cDNA RT Kit, and 10ng of cDNAs were amplified in a 7500 qPCR thermocycler. TaqMan gene expression assays were used to quantify AQP9 (Mm00508097_m1), GLUT2 (Mm00446229_m1), HSL (Mm00495359_m1), MCP-1 (Mm00441242_m1), PCK-1 (Mm01247058_m1), TNFα (Mm00443258_m1) and β-actin (Mm01205647_g1). To quantify the non-excised ILK sequence between exons within the floxed area number 6 and 7 in CRE-LOX mice, the following tandem primers were specially designed to be used with SYBR Green Master Mix: GGGCTCTTGTGAGCTTCTGT and GAGTGGTCCCCTTCCAGAAT [8, 11] . SYBR Green Master Mix and primers tandems were used to quantify GLUT4 (ATGGCTGTCGCTGGTTTCTC and TAAGGACCCATAGCATCCGC) and β-actin (GACGGCCAGGTCATCACTAT and CTTCTGCATCCTGTCAGCAA). Amplification values were normalized to endogenous β-actin ones and the relative quantification normalized of gene expression 2^−ΔΔCT method was used.
Protein extraction and immunoblot analysis
Tissues (epididymal WAT, vastus or liver) collected from fasting mice exposed to the diets (STD or HFD) during 2 or 6 weeks were homogenized in lysis buffer (10 mM Tris-HCl, pH 7.6; 1% Triton X-100; 1 mM EDTA; 0.1% sodium deoxycholate) supplemented with protease and phosphatase inhibitors (Complete and PhosSTOP, Roche, Basel, Switzerland). Protein concentrations were determined by DC-Protein Assay (Bio-Rad, Hercules, CA, USA). Equal amounts were separated on SDS-polyacrylamide gels and transferred to 0.2µm-PVDF membranes (Bio-Rad, Hercules, CA, USA). Membranes were blocked, incubated with primary antibodies against GLUT4 (Santa Cruz, Dallas, TX, USA), ILK (Cell Signaling Technology, Inc., Danvers, MA, USA), Actin or GAPDH (Sigma-Aldrich, St. Louis, MO, USA), and secondary antibodies (Merck-Millipore, Billerica, MA, USA or Dako, Glostrup, Denmark) afterwards. Immunoblots were detected by chemiluminescence (Pierce ECL Western Blotting Substrate, Thermo Fisher Scientific Waltham, MA, USA) and imaged with ImageQuant LAS 500 System (General Electric Healthcare, Little Chalfont, Buckinghamshire, United Kingdom). Densitometries were measured using ImageJ software (NIH). Actin and GAPDH proteins were used as endogenous control.
Statistics
The data are represented as the means ± SEMs of a variable number of experiments detailed in the figure legends. Student's t test was used for 2 groups and 1-or 2-way analysis of variance was used for >2 groups (ANOVA) followed by Bonferroni's post hoc tests. Differences in mean values were considered statistically significant at a probability level of less than 5% (p < 0.05). Power of the study was 80-85%, depending on the number of animals per experiment, with a confidence level of 95%.
Results
In vivo transgenical ILK depletion exacerbates the disruption of glycaemic and lipidic patterns under a short-term HFD challenge
In our previous works we nominated "conditional knock-down" ILK mice (cKD-ILK) to the adult animals where ILK expression levels of mRNA and protein are partially depleted in adipose and skeletal muscle between other tissues, compared to their control littermates with the same transgenic background, but without ILK depletion (CT) [9, 12] .
In order to study the role of ILK at the beginning of insulin resistance-related glycemic imbalance based in a HFD model, we challenged cKD-ILK or CT for 2 and 6 weeks with HFD or the matching STD (standard diet with low fat and sucrose). Diet composition, food and caloric intakes per 24 h of each group are shown in Table 1 . No differences were observed between CT and cKD-ILK intakes subjected to the same diet. Both CT and cKD-ILK food intakes were slightly shorter under HFD compared to STD, although calories ingestion was higher in HFD-fed mice due to its caloric density. The reduced HFD ingestion is probably due to food adaptation, as observed in others similar models [15] [16] [17] [18] . Biochemical determinations in blood, weight gains and other metabolic values where followed in fasting conditions along the 6 weeks of HFD in the same animals at the time points 0, 2 and 6 weeks. Fig. 1A show that basal fasting glycaemia in cKD-ILK was significantly higher than CT at time 0 of HFD, in accordance with our previous work [9] . During the HFD challenge, glycaemia progressively increased in both groups the 2nd week and steadily maintained high the 6th week of HFD.
The highest values were reach by HFD-fed cKD-ILK as early as the 2nd week, surpassing the values of CT counterparts at the same time. Fig. 1B shows a similar pattern of fasting insulinemia from HFD-fed mice, being cKD-ILK those reaching the highest insulinemia at the 2nd week, although basal values between cKD-ILK and CT were not different at time 0 [9] . Glycaemia and insulinemia values from the same animal can be combined together to represent a reliable approximation of insulin resistance grade by using HOMA-IR indexes. These are the ratio changes (means + SEM) of HOMA-IR compared to CT 0 weeks from a total of n=12 of each group: CT 0w=1.08 + 0.12; CT 2w= 3.40 + 0.29*; CT 6w= 4.55 + 0.29*; cKD-ILK 0w= 1.47 + 0.12*,#; cKD-ILK 2w= 5.59 + 0.61*,#; cKD-ILK 6w= 5.43 + 0.42*,# , where *= P<0.05 vs 0w; #=P<0.05 vs CT at the same time point. These data confirmed the faster insulin sensitivity loss in cKD-ILK during the short-term exposure to HFD. To understand better the fragile glycemic profile along the 6 weeks, other group of cKD-ILK and CT were challenged to HFD for the same periods of time and subjected to intraperitoneal glucose tolerance tests (GTT). Fig. 1C shows the area under the glycemic curves resulted from the GTT (AUC). The 2nd week of HFD, AUC were progressively increased in both CT and cKD-ILK and maintained high the 6th week. cKD-ILK exhibited the greatest degree of glucose intolerance the 2nd week surpassing CT counterparts values. Because the glycaemic imbalance observed during HFD may be due to increased gluconeogenesis in the liver [3, 4] , cKD-ILK and CT mice challenged to HFD were subjected to an intraperitoneal pyruvate tolerance test (PTT), a precursor of Fig. 1D shows the glycemic values represented as AUC from the PTT, which progressively increased in both CT and cKD-ILK and maintained high the 6th
week. cKD-ILK exhibited the greatest degree of gluconeogenesis the 2nd week, surpassing CT counterparts. During HFD challenge in rodent models, body weight and circulating lipid determinants are changed [8, [15] [16] [17] [18] . Fig. 2A shows the body weight gains of cKD-ILK and CT along the HFD implementation (0, 2 and 6 weeks). At the beginning of the diet challenge (time 0 weeks of HFD), no differences were observed between cKD-ILK and CT, but the values progressively increased in both groups the 2nd week and steadily maintained high the 6th week of HFD. cKD-ILK reached the highest values as early as the 2nd week surpassing the values of CT counterparts at the same time. Fig. 2B show unaltered plasmatic triglycerides values along the HFD challenge in both cKDILK and CT. Fig. 2C and 2D show that only in CT mice, the plasmatic total cholesterol and HDL levels were significantly increased the 2nd week to drop back to basal levels the 6th week of HFD. In cKD-ILK, values remained unaltered through the 6 weeks. Because the lipid metabolites seems to be altered in cKD-ILK challenged with HFD, we determined the two circulating lipolysis products glycerol and free fatty acids (FFA). As shown in Fig. 2E , blood glycerol levels significantly increase in both CT and cKD-ILK the 2nd ILK expression is reduced in peripheral insulin-sensitive tissues at the early implementation of HFD, leading to glucose uptake deterioration in the tissues The biochemical parameters shown in the previous figures suggested that transgenic ILK downregulation relates to an early glycemic imbalance. Taking in consideration that we already demonstrated that cKD-ILK mice model featured basal hyperglycemia [9] and related to the partially depleted insulin-sensitive tisular ILK content (mRNA and protein), we further study the connection between ILK content and HFD challenge.
Thus, we subjected to HFD or STD for either 2 or 6 weeks to new groups of CT animals, where ILK is not transgenically depleted before the HFD challenge, and we determined the expression of ILK levels (either mRNA and/or protein contents) in some of their metabolic relevant tissues. Fig. 3 shows that HFD dramatically downregulated the mRNA expression levels of ILK in CT compared to STD-fed CT, as soon as the 2nd week and as the same extent the 6th week, in the following tissues: epididymal depot of WAT (Fig. 3A) , skeletal muscle (vastus, Fig. 3C ) and liver (Fig. 3D ). Fig. 3B, 3C , and 3E show that tisular ILK protein levels correlates with the mRNA downregulation in HFD-treated CT compared with STD-treated counterparts the 6th week. It is important to notice that the downregulation of WAT and skeletal muscle tisular expression of ILK in HFD-fed CT were at the same extent (around 50% decrease) to the already shown in basal cKD-ILK tissues [9] . 
STD HFD
Because we previously demonstrated that transgenic ILK downregulation in basal cKD-ILK relates intimately to the transcriptional downregulation of GLUT4 expression in WAT and skeletal muscle and its subsequent lack of functionality [9] , we wonder whether early ILK downregulation due to the HFD implementation was related with the glucose uptake deterioration in the tissue. Thus, we determined the expression of GLUT4 in the same CT studied in the previous figure. Fig. 4 shows GLUT4 expression pattern similar to ILK, where HFD dramatically downregulates the mRNA expression levels of GLUT4 compared to STD, as soon as the 2nd week, in CT epididymal WAT (Fig. 4A ) and vastus (Fig. 4D ). GLUT4 protein levels correlates with the mRNA downregulation in HFD-treated CT the 6th week ( Fig. 4B and  4E) . To link the deteriorated glucose homeostasis with the downregulated ILK expression due to the HFD implementation, we studied the functional activity of GLUT4 in WAT and Fig. 4 . Glucose transport profile in adipose and skeletal muscle tissues from CT during short-term STD or HFD challenges: GLUT4 expression and insulin-stimulated glucose uptake capacity. Fresh isolated epididymal white adipose tissue (eWAT) and vastus explants were extracted from CT fed with either STD or HFD for 2 or 6 weeks (w). Animals were maintained in fasting conditions before to extract the tissues and proceed to the determinations. skeletal muscle from CT challenged to either STD or HFD for 2 or 6 weeks. Tissues explants were manipulated ex-vivo, with or without the canonical stimulation of GLUT4-dependent glucose uptake by insulin. Fig. 4C and 4F show lower glucose uptake capabilities of WAT and vastus under insulin stimulation in HFD compared to STD at any time of diets exposure, consequent to the GLUT4 downregulations observed in HFD-treated CT and cKD-ILK [9] .
Transgenic and/or HFD-mediated ILK reduction in WAT co-relates with the imbalanced markers expression of WAT lipolysis and inflammation, hepatic gluconeogenesis and related metabolites transporters
In Fig. 2E we already saw that circulating glycerol is temporary increased in cKD-ILK under HFD challenge. Thus, we studied whether the lipolysis pattern in the adipose tissue is altered when ILK is downregulated, either when ILK is depleted by transgenesis and/or during HFD-challenge. Fig. 5A and 5B shows the expression levels of the lipolysis marker hormone-sensitive lipase (HSL) in WAT from CT and cKD-ILK subjected with HFD or STD for either 2 or 6 weeks. Fig. 5A shows the expression levels of the lipolysis marker hormonesensitive lipase (HSL) in WAT from CT and cKD-ILK subjected with HFD or STD for 2 weeks. cKD-ILK exhibited the greatest degree of HSL expression, surpassing CT counterparts values. Fig. 5B shows the expression levels of HSL in WAT from CT and cKD-ILK subjected with HFD or STD for 6 weeks. In this time point, CT fed with HFD reduced their HSL expression to a significant lower level than CT fed with STD. Although HFD-fed cKD-ILK levels where not different to STD-fed cKD-ILK, they remained significantly higher than HFD-fed CT. The temporary increase and drop of HSL expression correlates with the pattern of circulating glycerol shown in Fig. 2 .
Because the increase of pro-inflammatory adipokines expression in WAT is one of the well-known events that occurs during HFD-mediated adipocyte dysfunction in animal models [15] [16] [17] [18] , we studied mRNA levels of TNFα and MCP-1 in the same animal groups. Fig. 5C and 5D show that, under basal conditions, STD-fed cKD-ILK exhibited increased expression levels of TNFα compared to STD-fed CT, and once HFD was challenged for 2 ( Fig.  5C ) or 6 weeks (Fig. 5D ), CT and cKD-ILK animals increased their WAT expression at the same extent as the basal STD-fed cKD-ILK. Similarly, Fig. 5E and 5F show that STD-fed cKD-ILK exhibited a basal increase in the expression of MCP-1 cytokine. The 2nd week of HFD did not change the MCP-1 expression pattern in CT compared to basal, but increased in HFD-fed cKD-ILK surpassing the HFD-fed CT values (Fig. 5E ). The maximal peak of MCP-1 expression was reached the 6th week of HFD in both CT and cKD-ILK (Fig. 5F) .
As mentioned previously, glucose homeostasis is coordinated between peripheral tissues glucose uptakes and the endogenous glucose production by the liver [3, 4] . The increased stress to pyruvate in HFD-fed cKD-ILK shown in Fig. 1 together with the reduced expression of ILK in the liver shown in Fig. 3 implies a relation between hepatic ILK and gluconeogenesis during HFD challenge. The expression levels of the hepatic glycerolindependent gluconeogenesis limiting enzyme phosphoenolpyruvate carboxykinase 1 (PCK-1) are shown in the 2 weeks ( Fig. 6A ) and 6 weeks ( Fig. 6B ) diets challenge. During HFD, the expression was higher in both genotypes than STD-fed animals. 2 weeks HFD-fed cKD-ILK exhibited the greatest PCK-1 expression values (Fig. 6A ). This peak of expression was reached by CT and cKD-ILK groups the 6th week, without differences between them (Fig.  6B) . We further asked whether hepatic transporters for glucose and glycerol were changing their expression pattern by hepatic ILK downregulation shown in Fig. 3 and its implication in the imbalanced glucose and glycerol values observed in the blood of HFD-challenged mice, already shown in Fig. 1 and Fig. 2 .
The main hepatic glycerol transporter AQP9 increase its expression after 2 weeks ( Fig.  6C ) and 6 weeks ( Fig. 6D) of HFD, following a similar pattern of expression as PCK-1 and in accordance to the circulating glycerol increase shown in Fig. 1 .
Under basal conditions during the 2 or 6 weeks of diet challenges, STD-fed cKD-ILK exhibited increased expression levels of the main hepatic glucose transporter GLUT2 ( Fig.  6E and 6F ). CT and cKD-ILK challenged for 2 weeks with HFD increased their hepatic GLUT2 expression at the same extent as the basal STD-fed cKD-ILK (Fig. 6E ). The 6th week of HFD challenge (Fig. 6F) , cKD-ILK livers reached the highest peak of GLUT2 expression, surpassing the HFD-fed CT.
Discussion
We demonstrated that transgenic or HFD-based ILK downregulation in the tissues relates with insulin resistance initiation during the early stages of a HFD-based model. Short term HFD models allow to study in few weeks the early stages of insulin impairment in relevant metabolic organs, which mimics a "pre-diabetes" state, whereas longer diet periods are devoted to study the clear "clinical" induction of obesity and diabetes [8, [15] [16] [17] [18] . In cKD-ILK the ILK expression is blunted by transgenesis in insulin-sensitive tissues, under basal STD conditions and before to any HFD challenge [8] . Interestingly, the ILK downregulation itself in these animals is directly co-related with increased expression of pro-inflammatory WAT cytokines TNFα and MCP-1, decreased GLUT4 presence and increase hepatic GLUT2. Furthermore, at this basal point we may dissociate the effect of ILK-mediated changes in metabolism from the "preliminary" obesity state, because STD-fed cKD-ILK have those and other metabolic-related parameters imbalanced but are not accompanied by body weight changes [9] . Although we and others have shown that ILK deletion in other tissues may trigger anti-inflammatory effects [19] [20] [21] [22] and considering that cytokines are in turn ILK expression modulators [23, 24] , our results suggest that ILK loss is able to modulate the expression of pro-inflammatory cytokines in metabolic-relevant tissues in accordance with other studies [25] . Moreover, the increased WAT cytokines may deregulate GLUT4 [26] [27] [28] [29] and it is possible that ILK-dependent WAT-originated cytokines downregulates GLUT4. In any case, our results are not conclusive to assure whether ILK downregulation is the cause or the consequence of the pro-inflammatory state. Once the HFD is implemented, those pathological parameters are remarkably exacerbated in cKD-ILK when compared to the rest of counterparts, reaching maximum responses at very early stages, the 2nd week at the most of the cases. The imbalanced expressions of GLUT4 and GLUT2 are exacerbated and extended to the hepatic glycerol transporter AQP9 upregulation in HFD-fed cKD-ILK. This is probably related with the striking decrease of glucose disposal capability in WAT and muscle of HFD-stimulated cKD-ILK, the consequent hyperglycemia exacerbation, as well as further increase of body weight, WAT pro-inflammation and hepatic gluconeogenesis.
Because misbalanced metabolism implicates several tissues and conditions, the obesity or its establishment might be the origin but also the consequence of insulin resistance [30] . Although we think that ILK transgenic depletion can be dissociated from changes in body weight under STD conditions [9] , the HFD-fed cKD-ILK rapidly increased their body weight, suggesting that ILK may relate with the development of obesity.
Other works with specific and non-inducible deletions of skeletal or hepatic ILK, basally or under HFD challenge, showed different insulin sensitive behaviors [10, [31] [32] [33] in contrast to our aggravated model. Without regards on the transgenic model used, our CT animals (where no transgenic ILK downregulation occurs at the initiation of the experiment) reached the dramatic downregulation of ILK expression in insulin-sensitive tissues as early as 2 weeks of HFD implementation. This is a very important highlight from our work: the ILK downregulation in such an early stage during the implementation or a HFD model may be a precise indicative of the original impairment of the modulation of metabolites.
The blood lipid profile in HFD animal models vary depending of several factors such as the animal genetic background, the percentage and nature of the fat or sugars used in the diet, the specific length of the HFD challenge or the fasting conditions when the animals were tested [8, [15] [16] [17] [18] 34] . In our case, blood triglyceride was not different between animal groups. A temporary increase in total cholesterol and HDL levels in HFD-fed CT, but not in cKD-ILK counterparts, may be associated to a great flow of cholesterol adaptation [35] that disappeared the 6th week, and probably the adaptive mechanism was early blunted in cKD-ILK because an original ILK-based impairment.
Increased WAT lipolysis, quantified by circulating glycerol or HSL expression, is uncontrolled during chronic metabolic diseases [2, [35] [36] [37] . We observed early but apparently temporal increases of HSL expression and circulating glycerol. HFD-fed cKD-ILK reached the maximum of this lipolysis-like effect, and it can be understood as an autocrine effect of the increased WAT-originated cytokines [38] [39] [40] and/or the blocked mediation of the ILKdependent downstream substrate AKT [2, 41] . Circulating FFA levels were not modified in our model, as previously observed in others´ short-term HFD models under fasting conditions [42, 43] . Some hypothesis to explain this point to the lack of "unrestrained" lipolysis in such a short-term HFD. Moreover, and considering the necessities of the fasted organism and the nutrient fluxes cross-talk between different organs, FFAs may substantially re-esterify into the adipocyte, or even be satisfactorily transported, up-taken and oxidized by other tissues [2, 3, 15-18, 34, 42, 43] .
Activated hepatic gluconeogenesis is another source of hyperglycemia, where the substrate could be the increased plasmatic glycerol and/or other glycerol-independent gluconeogenesis catalyzed by overexpressed PCK-1 [4] . In our model, ILK downregulation inversely correlated with increased hepatic gluconeogenesis, in accordance with others´ hepatocyte-specific ILK knockout mice [31] . The hepatic expression of ILK was also downregulated in HFD-fed CT, in accordance with previous reports [33] . ILK-depletion (transgenic or HFD-induced) did not change liver weight (data not shown), in contraposition to other ILK-depleted model [32] . We hypothesize that ILK loss increases the circulating glycerol and inversely modulates hepatic PCK-1 expression. It is probable that ILK-dependent hepatic AKT downregulation [41] is not able to blockade FOXO1-dependent PCK-1 promoter activity [44, 45] . Increased gluconeogenesis in our model, and in accordance with others' works, demanded for increased metabolites transport [46] as hepatic AQP9 [47, 48] and GLUT2 [6] . The unbalanced expression of the transmembrane transporters studied in this work (GLUT4, GLUT2 and AQP9) have been extensively observed in insulin-resistant and obese subjects and animal models [5, 6, 7, [47] [48] [49] [50] [51] [52] [53] . We [9] [10] [11] [12] [13] [14] and indirectly others [11] demonstrated ILK-mediated transcriptional regulation of GLUT4 and AQP2, and here we observed that ILK downregulation during the HFD challenge converge with the unbalanced expression of those metabolite transporters, and interestingly opposite expression profiles of GLUT4 versus GLUT2 and AQP9 in the same animals are followed by the same ILK downregulation.
Conclusion
Considering all this, ILK presence loss might be a transcriptional master key of metabolites transporters and other inflammatory and metabolic markers. We conclude that ILK expression in peripheral tissues is an important predictive value during the early progression of insulin resistance and it may contribute in the pathogenesis of metabolic disorders.
